2 active not recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Long COVID: new trials by email Literature Review of Long COVID trials Research Report on Long COVID
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 Prednisolone, Losartan - COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle | Phase 3 | Active not recruiting | Valentina Puentmann | 279 | 2022-12-12 | 2025-12-09 |
| Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis Sirolimus - Pulmonary Fibrosis, COVID-19 Pneumonia | Phase 2 / Phase 3 | Active not recruiting | University of Chicago | 60 | 2021-07-09 | 2025-12-15 |
Post-Acute COVID-19 Syndrome (2) · Microvascular Angina (1) · Myocarditis (1) · Pericarditis (1) · Pulmonary Fibrosis (1) · Vascular Remodeling (1) · Ventricular Dysfunction, Left (1) · Ventricular Remodeling (1)
COVID-19 (2) · Chronic Disease (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Disease Attributes (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Pneumonia (2) · Pneumonia, Viral (2) · Post-Infectious Disorders (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2)
Losartan (1) · Prednisolone (1) · Sirolimus (1)
University of Chicago (1) · Valentina Puentmann (1)
Austria (1) · Germany (1) · United States (1)
Ayodeji Adegunsoye, MD, MS (1) · Eike Nagel, MD, PhD (1) · Valentina Puntmann, MD, PhD (1)